- Home
- CLPS vs ACXP Comparison
CLPS vs ACXP Comparison
Compare CLPS & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- ACXP
- Stock Information
- Founded
- CLPS 2005
- ACXP 2017
- Country
- CLPS Hong Kong
- ACXP United States
- Employees
- CLPS N/A
- ACXP N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- ACXP Health Care
- Exchange
- CLPS Nasdaq
- ACXP Nasdaq
- Market Cap
- CLPS 35.1M
- ACXP 31.4M
- IPO Year
- CLPS 2018
- ACXP 2021
- Fundamental
- Price
- CLPS $1.26
- ACXP $0.77
- Analyst Decision
- CLPS
- ACXP Strong Buy
- Analyst Count
- CLPS 0
- ACXP 1
- Target Price
- CLPS N/A
- ACXP $12.00
- AVG Volume (30 Days)
- CLPS 20.4K
- ACXP 479.2K
- Earning Date
- CLPS 03-04-2025
- ACXP 03-14-2025
- Dividend Yield
- CLPS 10.66%
- ACXP N/A
- EPS Growth
- CLPS N/A
- ACXP N/A
- EPS
- CLPS N/A
- ACXP N/A
- Revenue
- CLPS $142,812,726.00
- ACXP N/A
- Revenue This Year
- CLPS N/A
- ACXP N/A
- Revenue Next Year
- CLPS N/A
- ACXP N/A
- P/E Ratio
- CLPS N/A
- ACXP N/A
- Revenue Growth
- CLPS N/A
- ACXP N/A
- 52 Week Low
- CLPS $0.68
- ACXP $0.68
- 52 Week High
- CLPS $1.70
- ACXP $3.35
- Technical
- Relative Strength Index (RSI)
- CLPS 59.67
- ACXP 45.19
- Support Level
- CLPS $1.20
- ACXP $0.70
- Resistance Level
- CLPS $1.28
- ACXP $0.87
- Average True Range (ATR)
- CLPS 0.07
- ACXP 0.06
- MACD
- CLPS 0.00
- ACXP 0.01
- Stochastic Oscillator
- CLPS 74.89
- ACXP 34.83
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.